カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の注射用ベンダムスチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Bendamustine for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19172）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19172
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の注射用ベンダムスチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

注射用ベンダムスチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の注射用ベンダムスチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

注射用ベンダムスチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・25mg注射剤、100mg注射剤、その他

用途別セグメントは次のように区分されます。
・慢性リンパ性白血病、多発性骨髄腫、非ホジキンリンパ腫

世界の注射用ベンダムスチン市場の主要な市場プレーヤーは以下のとおりです。
・Teva、Eisai、Eagle Pharmaceuticals、MundiPharma、Mylan、Natco Pharma、Emcure、Miracalus Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、注射用ベンダムスチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な注射用ベンダムスチンメーカーの企業概要、2019年～2022年までの注射用ベンダムスチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な注射用ベンダムスチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別注射用ベンダムスチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの注射用ベンダムスチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での注射用ベンダムスチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および注射用ベンダムスチンの産業チェーンを掲載しています。
・第13、14、15章では、注射用ベンダムスチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 注射用ベンダムスチンの概要
- 種類別分析（2017年vs2021年vs2028年）：25mg注射剤、100mg注射剤、その他
- 用途別分析（2017年vs2021年vs2028年）：慢性リンパ性白血病、多発性骨髄腫、非ホジキンリンパ腫
- 世界の注射用ベンダムスチン市場規模・予測
- 世界の注射用ベンダムスチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Teva、Eisai、Eagle Pharmaceuticals、MundiPharma、Mylan、Natco Pharma、Emcure、Miracalus Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：25mg注射剤、100mg注射剤、その他
・用途別分析2017年-2028年：慢性リンパ性白血病、多発性骨髄腫、非ホジキンリンパ腫
・注射用ベンダムスチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・注射用ベンダムスチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・注射用ベンダムスチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・注射用ベンダムスチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・注射用ベンダムスチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Bendamustine for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bendamustine for Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Chronic Lymphocytic Leukemia accounting for % of the Bendamustine for Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 25mg Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bendamustine for Injection include Teva, Eisai, Eagle Pharmaceuticals, MundiPharma, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bendamustine for Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
25mg Injection
100mg Injection
Other
Market segment by Application can be divided into
Chronic Lymphocytic Leukemia
Multiple Myeloma
Non-Hodgkin’s Lymphoma
The key market players for global Bendamustine for Injection market are listed below:
Teva
Eisai
Eagle Pharmaceuticals
MundiPharma
Mylan
Natco Pharma
Emcure
Miracalus Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bendamustine for Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bendamustine for Injection, with price, sales, revenue and global market share of Bendamustine for Injection from 2019 to 2022.
Chapter 3, the Bendamustine for Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bendamustine for Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bendamustine for Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bendamustine for Injection.
Chapter 13, 14, and 15, to describe Bendamustine for Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Bendamustine for Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bendamustine for Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 25mg Injection
1.2.3 100mg Injection
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Bendamustine for Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Multiple Myeloma
1.3.4 Non-Hodgkin’s Lymphoma
1.4 Global Bendamustine for Injection Market Size & Forecast
1.4.1 Global Bendamustine for Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bendamustine for Injection Sales in Volume (2017-2028)
1.4.3 Global Bendamustine for Injection Price (2017-2028)
1.5 Global Bendamustine for Injection Production Capacity Analysis
1.5.1 Global Bendamustine for Injection Total Production Capacity (2017-2028)
1.5.2 Global Bendamustine for Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bendamustine for Injection Market Drivers
1.6.2 Bendamustine for Injection Market Restraints
1.6.3 Bendamustine for Injection Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Bendamustine for Injection Product and Services
2.1.4 Teva Bendamustine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eisai
2.2.1 Eisai Details
2.2.2 Eisai Major Business
2.2.3 Eisai Bendamustine for Injection Product and Services
2.2.4 Eisai Bendamustine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Eagle Pharmaceuticals
2.3.1 Eagle Pharmaceuticals Details
2.3.2 Eagle Pharmaceuticals Major Business
2.3.3 Eagle Pharmaceuticals Bendamustine for Injection Product and Services
2.3.4 Eagle Pharmaceuticals Bendamustine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 MundiPharma
2.4.1 MundiPharma Details
2.4.2 MundiPharma Major Business
2.4.3 MundiPharma Bendamustine for Injection Product and Services
2.4.4 MundiPharma Bendamustine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Bendamustine for Injection Product and Services
2.5.4 Mylan Bendamustine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Natco Pharma
2.6.1 Natco Pharma Details
2.6.2 Natco Pharma Major Business
2.6.3 Natco Pharma Bendamustine for Injection Product and Services
2.6.4 Natco Pharma Bendamustine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Emcure
2.7.1 Emcure Details
2.7.2 Emcure Major Business
2.7.3 Emcure Bendamustine for Injection Product and Services
2.7.4 Emcure Bendamustine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Miracalus Pharma
2.8.1 Miracalus Pharma Details
2.8.2 Miracalus Pharma Major Business
2.8.3 Miracalus Pharma Bendamustine for Injection Product and Services
2.8.4 Miracalus Pharma Bendamustine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bendamustine for Injection Breakdown Data by Manufacturer
3.1 Global Bendamustine for Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bendamustine for Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bendamustine for Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Bendamustine for Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Bendamustine for Injection Manufacturer Market Share in 2021
3.5 Global Bendamustine for Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bendamustine for Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bendamustine for Injection Market Size by Region
4.1.1 Global Bendamustine for Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Bendamustine for Injection Revenue by Region (2017-2028)
4.2 North America Bendamustine for Injection Revenue (2017-2028)
4.3 Europe Bendamustine for Injection Revenue (2017-2028)
4.4 Asia-Pacific Bendamustine for Injection Revenue (2017-2028)
4.5 South America Bendamustine for Injection Revenue (2017-2028)
4.6 Middle East and Africa Bendamustine for Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bendamustine for Injection Sales in Volume by Type (2017-2028)
5.2 Global Bendamustine for Injection Revenue by Type (2017-2028)
5.3 Global Bendamustine for Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bendamustine for Injection Sales in Volume by Application (2017-2028)
6.2 Global Bendamustine for Injection Revenue by Application (2017-2028)
6.3 Global Bendamustine for Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bendamustine for Injection Sales by Type (2017-2028)
7.2 North America Bendamustine for Injection Sales by Application (2017-2028)
7.3 North America Bendamustine for Injection Market Size by Country
7.3.1 North America Bendamustine for Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Bendamustine for Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bendamustine for Injection Sales by Type (2017-2028)
8.2 Europe Bendamustine for Injection Sales by Application (2017-2028)
8.3 Europe Bendamustine for Injection Market Size by Country
8.3.1 Europe Bendamustine for Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Bendamustine for Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bendamustine for Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Bendamustine for Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Bendamustine for Injection Market Size by Region
9.3.1 Asia-Pacific Bendamustine for Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bendamustine for Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bendamustine for Injection Sales by Type (2017-2028)
10.2 South America Bendamustine for Injection Sales by Application (2017-2028)
10.3 South America Bendamustine for Injection Market Size by Country
10.3.1 South America Bendamustine for Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Bendamustine for Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bendamustine for Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Bendamustine for Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Bendamustine for Injection Market Size by Country
11.3.1 Middle East & Africa Bendamustine for Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bendamustine for Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bendamustine for Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bendamustine for Injection
12.3 Bendamustine for Injection Production Process
12.4 Bendamustine for Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bendamustine for Injection Typical Distributors
13.3 Bendamustine for Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Bendamustine for Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Bendamustine for Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Bendamustine for Injection Product and Services
Table 6. Teva Bendamustine for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eisai Basic Information, Manufacturing Base and Competitors
Table 8. Eisai Major Business
Table 9. Eisai Bendamustine for Injection Product and Services
Table 10. Eisai Bendamustine for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Eagle Pharmaceuticals Major Business
Table 13. Eagle Pharmaceuticals Bendamustine for Injection Product and Services
Table 14. Eagle Pharmaceuticals Bendamustine for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. MundiPharma Basic Information, Manufacturing Base and Competitors
Table 16. MundiPharma Major Business
Table 17. MundiPharma Bendamustine for Injection Product and Services
Table 18. MundiPharma Bendamustine for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Bendamustine for Injection Product and Services
Table 22. Mylan Bendamustine for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Natco Pharma Major Business
Table 25. Natco Pharma Bendamustine for Injection Product and Services
Table 26. Natco Pharma Bendamustine for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Emcure Basic Information, Manufacturing Base and Competitors
Table 28. Emcure Major Business
Table 29. Emcure Bendamustine for Injection Product and Services
Table 30. Emcure Bendamustine for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Miracalus Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Miracalus Pharma Major Business
Table 33. Miracalus Pharma Bendamustine for Injection Product and Services
Table 34. Miracalus Pharma Bendamustine for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Bendamustine for Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Bendamustine for Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Bendamustine for Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Bendamustine for Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Bendamustine for Injection Production Site of Key Manufacturer
Table 40. Bendamustine for Injection New Entrant and Capacity Expansion Plans
Table 41. Bendamustine for Injection Mergers & Acquisitions in the Past Five Years
Table 42. Global Bendamustine for Injection Sales by Region (2017-2022) & (K Units)
Table 43. Global Bendamustine for Injection Sales by Region (2023-2028) & (K Units)
Table 44. Global Bendamustine for Injection Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Bendamustine for Injection Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Bendamustine for Injection Sales by Type (2017-2022) & (K Units)
Table 47. Global Bendamustine for Injection Sales by Type (2023-2028) & (K Units)
Table 48. Global Bendamustine for Injection Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Bendamustine for Injection Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Bendamustine for Injection Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Bendamustine for Injection Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Bendamustine for Injection Sales by Application (2017-2022) & (K Units)
Table 53. Global Bendamustine for Injection Sales by Application (2023-2028) & (K Units)
Table 54. Global Bendamustine for Injection Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Bendamustine for Injection Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Bendamustine for Injection Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Bendamustine for Injection Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Bendamustine for Injection Sales by Country (2017-2022) & (K Units)
Table 59. North America Bendamustine for Injection Sales by Country (2023-2028) & (K Units)
Table 60. North America Bendamustine for Injection Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Bendamustine for Injection Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Bendamustine for Injection Sales by Type (2017-2022) & (K Units)
Table 63. North America Bendamustine for Injection Sales by Type (2023-2028) & (K Units)
Table 64. North America Bendamustine for Injection Sales by Application (2017-2022) & (K Units)
Table 65. North America Bendamustine for Injection Sales by Application (2023-2028) & (K Units)
Table 66. Europe Bendamustine for Injection Sales by Country (2017-2022) & (K Units)
Table 67. Europe Bendamustine for Injection Sales by Country (2023-2028) & (K Units)
Table 68. Europe Bendamustine for Injection Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Bendamustine for Injection Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Bendamustine for Injection Sales by Type (2017-2022) & (K Units)
Table 71. Europe Bendamustine for Injection Sales by Type (2023-2028) & (K Units)
Table 72. Europe Bendamustine for Injection Sales by Application (2017-2022) & (K Units)
Table 73. Europe Bendamustine for Injection Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Bendamustine for Injection Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Bendamustine for Injection Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Bendamustine for Injection Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Bendamustine for Injection Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Bendamustine for Injection Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Bendamustine for Injection Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Bendamustine for Injection Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Bendamustine for Injection Sales by Application (2023-2028) & (K Units)
Table 82. South America Bendamustine for Injection Sales by Country (2017-2022) & (K Units)
Table 83. South America Bendamustine for Injection Sales by Country (2023-2028) & (K Units)
Table 84. South America Bendamustine for Injection Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Bendamustine for Injection Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Bendamustine for Injection Sales by Type (2017-2022) & (K Units)
Table 87. South America Bendamustine for Injection Sales by Type (2023-2028) & (K Units)
Table 88. South America Bendamustine for Injection Sales by Application (2017-2022) & (K Units)
Table 89. South America Bendamustine for Injection Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Bendamustine for Injection Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Bendamustine for Injection Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Bendamustine for Injection Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Bendamustine for Injection Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Bendamustine for Injection Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Bendamustine for Injection Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Bendamustine for Injection Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Bendamustine for Injection Sales by Application (2023-2028) & (K Units)
Table 98. Bendamustine for Injection Raw Material
Table 99. Key Manufacturers of Bendamustine for Injection Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Bendamustine for Injection Typical Distributors
Table 103. Bendamustine for Injection Typical Customers
List of Figures
Figure 1. Bendamustine for Injection Picture
Figure 2. Global Bendamustine for Injection Revenue Market Share by Type in 2021
Figure 3. 25mg Injection
Figure 4. 100mg Injection
Figure 5. Other
Figure 6. Global Bendamustine for Injection Revenue Market Share by Application in 2021
Figure 7. Chronic Lymphocytic Leukemia
Figure 8. Multiple Myeloma
Figure 9. Non-Hodgkin's Lymphoma
Figure 10. Global Bendamustine for Injection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Bendamustine for Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Bendamustine for Injection Sales (2017-2028) & (K Units)
Figure 13. Global Bendamustine for Injection Price (2017-2028) & (US$/Unit)
Figure 14. Global Bendamustine for Injection Production Capacity (2017-2028) & (K Units)
Figure 15. Global Bendamustine for Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Bendamustine for Injection Market Drivers
Figure 17. Bendamustine for Injection Market Restraints
Figure 18. Bendamustine for Injection Market Trends
Figure 19. Global Bendamustine for Injection Sales Market Share by Manufacturer in 2021
Figure 20. Global Bendamustine for Injection Revenue Market Share by Manufacturer in 2021
Figure 21. Bendamustine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Bendamustine for Injection Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Bendamustine for Injection Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Bendamustine for Injection Sales Market Share by Region (2017-2028)
Figure 25. Global Bendamustine for Injection Revenue Market Share by Region (2017-2028)
Figure 26. North America Bendamustine for Injection Revenue (2017-2028) & (USD Million)
Figure 27. Europe Bendamustine for Injection Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Bendamustine for Injection Revenue (2017-2028) & (USD Million)
Figure 29. South America Bendamustine for Injection Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Bendamustine for Injection Revenue (2017-2028) & (USD Million)
Figure 31. Global Bendamustine for Injection Sales Market Share by Type (2017-2028)
Figure 32. Global Bendamustine for Injection Revenue Market Share by Type (2017-2028)
Figure 33. Global Bendamustine for Injection Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Bendamustine for Injection Sales Market Share by Application (2017-2028)
Figure 35. Global Bendamustine for Injection Revenue Market Share by Application (2017-2028)
Figure 36. Global Bendamustine for Injection Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Bendamustine for Injection Sales Market Share by Type (2017-2028)
Figure 38. North America Bendamustine for Injection Sales Market Share by Application (2017-2028)
Figure 39. North America Bendamustine for Injection Sales Market Share by Country (2017-2028)
Figure 40. North America Bendamustine for Injection Revenue Market Share by Country (2017-2028)
Figure 41. United States Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Bendamustine for Injection Sales Market Share by Type (2017-2028)
Figure 45. Europe Bendamustine for Injection Sales Market Share by Application (2017-2028)
Figure 46. Europe Bendamustine for Injection Sales Market Share by Country (2017-2028)
Figure 47. Europe Bendamustine for Injection Revenue Market Share by Country (2017-2028)
Figure 48. Germany Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Bendamustine for Injection Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Bendamustine for Injection Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Bendamustine for Injection Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Bendamustine for Injection Revenue Market Share by Region (2017-2028)
Figure 57. China Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Bendamustine for Injection Sales Market Share by Type (2017-2028)
Figure 64. South America Bendamustine for Injection Sales Market Share by Application (2017-2028)
Figure 65. South America Bendamustine for Injection Sales Market Share by Country (2017-2028)
Figure 66. South America Bendamustine for Injection Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Bendamustine for Injection Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Bendamustine for Injection Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Bendamustine for Injection Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Bendamustine for Injection Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Bendamustine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Bendamustine for Injection in 2021
Figure 78. Manufacturing Process Analysis of Bendamustine for Injection
Figure 79. Bendamustine for Injection Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ベンダムスチン塩酸塩粉末の世界市場2023年：25mg/個、100mg/個
  • 世界のリラグルチド注射市場2022年：市場規模予測（～2028年）
  • 世界のエダラボン注射市場2022年：市場規模予測（～2028年）
  • 世界のバシリキシマブ注射市場2022年：市場規模予測（～2028年）
  • 世界のクリスビタ注射市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19172 )"世界の注射用ベンダムスチン市場2022年：市場規模予測（～2028年）" (英文：Global Bendamustine for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。